Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by CancerVAX, Inc
CancerVax Achieves Major Milestone in Activating Human Killer T-Cells Against Cancer
Today 20:35 EDT
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Named a Top Preclinical Biotech Company of 2026 by Life Sciences Review
July 28, 2026
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Develops Novel Smart mRNA to Harness Pre-Existing Immunity in 99% of World Population
July 14, 2026
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Successfully Demonstrates Full Nanoparticle Delivery in Mouse Study
June 15, 2026
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax to Target Colorectal Cancer Following Recent Biodistribution Breakthroughs
April 16, 2026
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Reports Successful Initial Mouse Study with Breakthrough Results
March 31, 2026
From
CancerVAX, Inc
Via
GlobeNewswire
Biotech Veteran and Virologist Joins CancerVax as Senior Scientific Advisor
January 27, 2026
From
CancerVAX, Inc
Via
GlobeNewswire
World-renowned Immunologist and Distinguished Scientist Joins CancerVax as Senior Scientific Advisor
January 07, 2026
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Reviews Major Scientific and Strategic Milestones Achieved in 2025
December 23, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Reports Nanoparticle Component Success in Preparation for Animal Studies
December 17, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Precision Therapy Successfully Avoids Healthy Liver Cells
October 14, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
Legendary Scientist and Biotech Veteran Joins CancerVax as Strategic Advisor
September 03, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Achieves Major Milestones and Files Foundational Patent Application
August 26, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
Scientists Discuss the Recent CancerVax Breakthrough
August 19, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Successfully Disguises Cancer Cells and Tricks Immune Cells into Attacking Them
August 05, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Nanoparticle Successfully Targets Cancer Cells While Sparing Non-cancerous Cells
June 19, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Targets Liver Cancers to Further Showcase Flexibility of Its Universal Platform
June 09, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Achieves Major Milestone with Successful Creation of Cell Targeting Nanoparticle
June 05, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Scientists Featured on Cytiva’s “Discovery Matters” Podcast Discussing Universal Cancer Vaccine Platform
June 03, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
Top Biotech Exec Joins CancerVax as Chief Scientific Advisor
February 27, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Announces Successful Tests of its Smart mRNA Technology
February 25, 2025
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Passes First Test with Flying Colors
December 20, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Targets Hard to Treat Pancreatic Cancer
December 11, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Lands Top Cancer Expert
November 19, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Taps Flashpoint Therapeutics’ Nanotechnology Platform to Drive Universal Cancer Treatment
August 29, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Files New Patent for Its Novel Universal Cancer Treatment Platform
August 27, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Adds Key Members to Its Research Team
August 01, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Successfully Uses Nobel Prize Chemistry to Achieve Universal Cancer Vaccine Targeting Milestone
May 21, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Announces Promising New Drug to Treat a Deadly Children’s Cancer
April 16, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Launches $5 Million Funding Round
April 03, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
